Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.590
+0.010 (0.63%)
Aug 21, 2026, 4:08 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 3.3 billion as of August 21, 2026. Its market cap has decreased by -34.82% in one year.
Market Cap
3.30B
Enterprise Value
3.58B
Revenue
1.92B
Ranking
n/a
PE Ratio
15.88
Stock Price
1.59
ChartMarket Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 3.30B, a decrease of -50.24%. That is a compound annual growth rate of -9.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.30B | -13.15% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 4.10B |
| Jacobio Pharmaceuticals Group | 3.98B |
| Hanx Biopharmaceuticals (Wuhan) | 3.96B |
| Qyuns Therapeutics | 3.66B |
| Mirxes Holding Company | 3.66B |
| Medtide | 3.18B |
| BioDlink International Company | 3.11B |
| Jiangsu Recbio Technology | 3.08B |